>>> Up
* H&M Raised to Neutral at Oddo BHF; PT 173 kronor
* Oxford Biomedica Raised to Buy at Deutsche Bank; PT 735 pence
* Rational Raised to Buy at UBS; PT 785 euros
* Rational Raised to Buy at UBS; PT 785 euros
* Rivian Raised to Outperform at Baird; PT $25
* Thyssenkrupp Nucera Raised to Buy at Deutsche Bank; PT 11 euros
>>> Down
>>> Down
* Argenx ADRs Cut to Neutral at Baird; PT $858
* Avidity Biosciences Cut to Inline at Evercore ISI; PT $72
* Bufab Cut to Hold at ABG; PT 105 kronor
* Diageo PT Cut to 1,530 pence from 1,595 pence at Morgan Stanley
* Evolution Cut to Underweight at Barclays; PT 575 kronor
* Hexagon Purus Cut to Sell at SB1 Markets; PT 1 krone
* Hexagon Purus Cut to Sell at SB1 Markets; PT 1 krone
* Tomra Cut to Sell at SB1 Markets; PT 110 kroner
* Voestalpine Cut to Hold at Erste Group; PT 39.50 euros
>>> Initiation
>>> Initiation
* Appear Rated New Buy at ABG; PT 100 kroner
* Autoliv GDRs Rated New Buy at SB1 Markets; PT 1,400 kronor
* Autoliv GDRs Rated New Buy at SB1 Markets; PT 1,400 kronor
* Avalo Therapeutics Rated New Outperform at Mizuho Securities
* Comet Rated New Outperform at Oddo BHF; PT 310 Swiss francs
* Elkem Rated New Buy at Arctic Securities; PT 35 kroner
* Eolus AB Rated New Buy at SB1 Markets; PT 60 kronor
* Inficon Rated New Neutral at Oddo BHF; PT 110 Swiss francs
* Magnora Rated New Buy at Arctic Securities; PT 32 kroner
* Norconsult Norge Rated New Buy at SB1 Markets; PT 55 kroner
* TX Group Rated New Outperform at Oddo BHF; PT 178 Swiss francs
>>> Call
>>> Call
* Comet New Outperform at Oddo BHF on Favorable Memory Exposure
* Evolution Double-Downgraded at Barclays on Weaker Growth Outlook
* Evolution Double-Downgraded at Barclays on Weaker Growth Outlook
* Inficon Neutral at Oddo BHF, High-Quality But Limited Upside6--
* Société Générale Price Objective Up as BofA Forecasts Profitability Rebound by FY28